Arrowstreet Capital Limited Partnership Has $2.47 Million Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS)

Arrowstreet Capital Limited Partnership lifted its position in PetMed Express, Inc. (NASDAQ:PETS - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 513,381 shares of the company's stock after acquiring an additional 107,614 shares during the period. Arrowstreet Capital Limited Partnership owned about 2.48% of PetMed Express worth $2,474,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. American Century Companies Inc. boosted its stake in PetMed Express by 15.3% in the 4th quarter. American Century Companies Inc. now owns 33,662 shares of the company's stock worth $162,000 after purchasing an additional 4,459 shares during the period. R Squared Ltd purchased a new stake in shares of PetMed Express in the fourth quarter valued at $31,000. Blair William & Co. IL boosted its position in shares of PetMed Express by 95.2% in the fourth quarter. Blair William & Co. IL now owns 20,300 shares of the company's stock worth $98,000 after buying an additional 9,900 shares during the period. Virtu Financial LLC acquired a new stake in shares of PetMed Express in the fourth quarter worth $58,000. Finally, JPMorgan Chase & Co. grew its holdings in shares of PetMed Express by 355.5% during the fourth quarter. JPMorgan Chase & Co. now owns 106,954 shares of the company's stock valued at $516,000 after buying an additional 83,473 shares in the last quarter. 73.33% of the stock is owned by hedge funds and other institutional investors.

PetMed Express Price Performance

PetMed Express stock traded down $0.01 during trading hours on Tuesday, hitting $3.02. The company had a trading volume of 33,702 shares, compared to its average volume of 303,573. PetMed Express, Inc. has a fifty-two week low of $2.90 and a fifty-two week high of $6.85. The firm has a market capitalization of $62.28 million, a P/E ratio of 301.80 and a beta of 0.99. The firm's fifty day moving average is $4.08 and its 200-day moving average is $4.51.

PetMed Express (NASDAQ:PETS - Get Free Report) last posted its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). PetMed Express had a return on equity of 0.37% and a net margin of 0.14%. Analysts anticipate that PetMed Express, Inc. will post 0.19 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded PetMed Express from a "buy" rating to a "hold" rating in a research note on Tuesday, February 11th.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.